We detected no significant difference between tumors with methylated or unmethylated UBE2L6 promoters and association with age, sex, cancer staging, lymph node metastasis or pathological subtypes (data not shown). The gene discussed is UBE2L6; the disease is metastatic malignant neoplasm in the lymph nodes.